1Y Close · As of Aug 26, 2026
THERAGEN ETEX operates in the Pharmaceuticals sector.
Legal name: THERAGEN ETEX CO.,LTD.
In fiscal year 2025, THERAGEN ETEX (066700) reported revenue of 271.6 billion KRW, up 8.8% from 249.6 billion KRW a year earlier.
Operating profit was 10.2 billion KRW and net income was 11.7 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 78.0 billion KRW, with a P/B of 0.49.
These figures can be verified in the DART filing (receipt no. 20260319001163).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 271.6B | 10.2B | 11.7B |
| 2024 | 249.6B | 12.5B | -39.3B |
| 2023 | 221.7B | 11.6B | 28.4B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |